CIK 0000034956 · Non-accelerated filer<br>Smaller reporting company
TENAX THERAPEUTICS, INC.
Sign in to watch- Ticker
- TENX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 262593535
- Phone
- 919-855-2100
- Business address
- 101 GLEN LENNOX DRIVE, SUITE 300, CHAPEL HILL, NC, 27517
- Former names
- OXYGEN BIOTHERAPEUTICS, INC., SYNTHETIC BLOOD INTERNATIONAL INC
- FWP Offering Free Writing Prospectus
- S-1/A Offering Registration Statement
- 10-Q Report Quarterly Report
- UPLOAD Other SEC-generated Letter
- S-1 Offering Registration Statement
- 10-Q Report Quarterly Report
- 4 Returned to the company CFO returned 5,720 shares (to the company)
- 8-K Event Shareholder vote results
- 8-K Event Executive or director change
- EFFECT Other Notice of Effectiveness
- UPLOAD Other SEC-generated Letter
- CORRESP Other Correspondence Between Filers and SEC Staff
- S-3 Offering Registration Statement
- 10-Q Report Quarterly Report
- DEF 14A Proxy Proxy Statement
- 4 Returned to the company CFO returned 6,425 shares (to the company)
- S-8 Other Securities Offered to Employees in Benefit Plans
- 10-K Report Annual Report
- 8-K Event Other events
- 8-K Event Bylaws or fiscal year change · Other events
Page 24 of 50 · 996 filings